Skip to content

The role of hormones in acute coronary syndrome (heart attack)

Significance of dehydroepiandrosterone-sulfate and gonadal sex hormones in acute coronary syndrome - sex-based differences

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN62480360
Enrollment
200
Registered
2023-12-18
Start date
2011-05-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome Circulatory System

Interventions

Sex steroids (E2, total testosterone [T]) and DHEA-S, oxidized low-density lipoproteins, high-sensitive C-reactive protein (CRP), white blood cell counts (WBC), and cardiac enzymes (creatine kinase [C

Sponsors

Medical University of Sofia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult men and women admitted to hospital with acute coronary syndrome.

Exclusion criteria

Exclusion criteria: Acute infectious disease, any diagnosed neoplastic disease; fracture, physical trauma or surgical procedure a month before and after the inclusion period and at the end of the follow-up.

Design outcomes

Primary

MeasureTime frame
1. Oxidized low-density lipoproteins (oxLDL), high-sensitive C-reactive protein (hsCRP), white blood cell counts (WBC), and cardiac enzymes (creatine kinase [CK], Muscle-Brain fraction of CK [CPK-MB], high-sensitive troponin T [hsTnT]) were evaluated in plasma obtained within two hours of coronary angiography (CAG) 2. Coronary disease severity, measured using SYNTAX score after CAG 3. Total 17ß-estradiol [E2], total testosterone [T], dehydroepiandrosterone-sulfate [DHEA-S] measured using blood samples drawn 48 hours after symptom onset

Secondary

MeasureTime frame
Patient information on obesity, diabetes mellitus and incidence of revascularizations, reinfarctions and deaths after one- year follow up measured using patient records.

Countries

Bulgaria

Contacts

Public ContactNiya Semerdzhieva
niaemilova@yahoo.com+359 988962418

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026